OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...

Tanner Health and Healthliant Ventures partner with Optellum to launch an artificial intelligence (AI) platform designed to detect lung cancer.

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before ...

As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...

Explore whether Canakinumab can prevent lung cancer, focusing on new research and the complexities of medical interpretations ...

New patent expands globally protected IP estate beyond blood into alternative biofluids, positioning the Company's clinical mass spectrometry platform against traditional genomic liquid biopsies.

Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...